Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases
worldwide and is often associated with aspects of metabolic syndrome. Despite its …

Nonalcoholic fatty liver disease (NAFLD) is a heterogeneous and complex disease that is
imprecisely diagnosed by liver biopsy. NAFLD covers a spectrum that ranges from simple …

The association of photosensitisers to peptides and proteins is a recognised and successful
method for enhancing the selectivity and efficacy of photodynamic treatment. The covalent …

Chromosomal rearrangements of the human MLL/KMT2A gene are associated with infant,
pediatric, adult and therapy-induced acute leukemias. Here we present the data obtained …

In the past few years, focus group research has been used increasingly in fields different
from market research, in which the technique was developed. The application of focus …

Background & Aims Nonalcoholic fatty liver disease (NAFLD) is a consequence of defects in
diverse metabolic pathways that involve hepatic accumulation of triglycerides. Features of …

Nonalcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in
most western countries. Current NAFLD diagnosis methods (eg, liver biopsy analysis or …

Although rarely, switches between lymphoid and myeloid lineages may occur during
treatment of acute leukemias (AL). Correct diagnosis relies upon confirmation by …

Insulin resistance and hepatic lipid accumulation constitute the metabolic underpinning of
nonalcoholic steatohepatitis (NASH). We tested the hypothesis that saroglitazar, a PPAR α/γ …

Nonalcoholic fatty liver disease (NAFLD) is the most common type of chronic liver disease
worldwide and includes a broad spectrum of histologic phenotypes, ranging from simple …